StockTipsArenaBeta

SELL Divi's Laboratories Limited — Elara Capital

SELLDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byElara CapitalHorizon: NA (inferred 1 year)9 Nov 2026via ET Now (Live)

Entry₹11,097Inferred
Target₹6,539
Total upside +41.07%
Stop lossNot given
CMP₹11,4421d ago
Active-3.11%+42.85%upside left 12 mo left
Follow Elara Capital for new calls(100% target hit, 36 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 6 other Long-term calls on DIVISLABSee 272 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:41 am IST
2 supporting4 neutral12 opposing
Supports the SELL call (2)

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·26 Oct · 3w ago

Neutral / worth noting (4)

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·7 Nov · 1w ago

(opens in new tab)
Weighs against the SELL call (12)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

Tata Steel, Divi's Labs In Focus After Q2 Results; HDFC Securities Sees Up To 34% Upside; Check New Target Prices

NewsNdtv-Profit·12 Nov · 2d ago

(opens in new tab)

Divi's Laboratories Market Cap Crosses Rs 3 Lakh Crore: What Is Driving The Rally

NewsNdtv-Profit·9 Nov · 5d ago

(opens in new tab)

Divi's Laboratories shares hit record high rising 84% YTD; buy, sell or hold after Q2 results 2026? Brokerages report

NewsLivemint·9 Nov · 5d ago

(opens in new tab)

Divi's Laboratories Q2 Review: Goldman Sachs, Jefferies, JPMorgan Raise Target Prices; Kotak Maintains Sell

NewsNdtv-Profit·9 Nov · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Elara Capital

Every call and its outcome